Exicure, Inc. (NASDAQ:XCUR – Get Free Report)’s share price rose 4.5% during mid-day trading on Wednesday . The stock traded as high as $2.80 and last traded at $2.79. Approximately 16,393 shares changed hands during trading, an increase of 23% from the average daily volume of 13,370 shares. The stock had previously closed at $2.67.
Exicure Price Performance
The company’s fifty day moving average is $3.67 and its 200-day moving average is $4.42. The stock has a market cap of $20.32 million, a PE ratio of -4.14 and a beta of 3.62.
Exicure (NASDAQ:XCUR – Get Free Report) last issued its earnings results on Friday, May 29th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($18.60) by $18.31.
About Exicure
Exicure is a clinical‐stage biotechnology company pioneering the development of next‐generation genetic medicines through its proprietary spherical nucleic acid (SNA) delivery platform. This nanotechnology‐based approach is designed to facilitate the intracellular delivery of oligonucleotide therapeutics, addressing longstanding challenges in targeting hard‐to‐reach tissues such as the central nervous system.
The company’s pipeline encompasses programs for neurological disorders—including Huntington’s disease, Parkinson’s disease and Alzheimer’s disease—as well as exploratory efforts in dermatological indications and oncology.
Recommended Stories
- Five stocks we like better than Exicure
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Exicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exicure and related companies with MarketBeat.com's FREE daily email newsletter.
